REARDON ANDREW (CLO & Secretary) reported 1 transaction at LIGAND PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/12/2025ACC: 0002001011-25-000061
Officer· CLO & Secretary
Since Mar 2026
-1.32K
Net shares
Net seller
$198.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.32K
Price / share
$150.06
Trade value
$198.83K
% of position
4.1%
8/10/2025
32.14K→30.81K
Total
Net shares
−1.32K
Net value
-$198.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2025 | F · Tax Withholding | −1.32K | $150.06 | $198.83K | 4.1% | 32.14K | 30.81K |
| Total | −1.32K | -$198.83K | ||||||
Derivative Transactions0
No derivative transactions reported